B.Riley FBR analyst Mayank Mamtani maintained a Buy rating on Acasti Pharma (ACST – Research Report) today and set a
Category: Healthcare
Second Sight Medical Products (EYES) Receives a Buy from H.C. Wainwright
In a report released today, Amit Dayal from H.C. Wainwright maintained a Buy rating on Second Sight Medical Products (EYES
Personalis (PSNL) Receives a Buy from Morgan Stanley
In a report released today, David Lewis from Morgan Stanley maintained a Buy rating on Personalis (PSNL – Research Report),
Collegium Pharmaceutical (COLL) Received its Third Buy in a Row
After William Blair and Gabelli gave Collegium Pharmaceutical (NASDAQ: COLL) a Buy rating last month, the company received another Buy,
Nucana (NCNA) Receives a Buy from Cowen & Co.
In a report released today, Boris Peaker from Cowen & Co. maintained a Buy rating on Nucana (NCNA – Research
Eton Pharmaceuticals (ETON) Gets a Buy Rating from B.Riley FBR
B.Riley FBR analyst Andrew D’silva maintained a Buy rating on Eton Pharmaceuticals (ETON – Research Report) today and set a
Maxim Group Maintains a Hold Rating on Sintx Technologies (SINT)
Maxim Group analyst Tate Sullivan maintained a Hold rating on Sintx Technologies (SINT – Research Report) yesterday. The company’s shares